Cargando…
Potentiation of Insulin Signaling Contributes to Heart Failure in Type 2 Diabetes: A Hypothesis Supported by Both Mechanistic Studies and Clinical Trials
The heightened risk of heart failure in type 2 diabetes cannot be explained by the occurrence of clinically overt myocardial ischemic events or hyperglycemia. Experimentally, insulin exerts detrimental effects on the heart, vasculature, kidneys, and adipose tissue that can lead to heart failure. In...
Autor principal: | Packer, Milton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058949/ https://www.ncbi.nlm.nih.gov/pubmed/30062227 http://dx.doi.org/10.1016/j.jacbts.2018.04.003 |
Ejemplares similares
-
Molecular Epidemiology of Heart Failure: Translational Challenges and Opportunities
por: Smith, J. Gustav
Publicado: (2017) -
Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
por: Halliday, Brian P., et al.
Publicado: (2022) -
Advancing the Science of Myocardial Recovery With Mechanical Circulatory Support: A Working Group of the National, Heart, Lung, and Blood Institute
por: Drakos, Stavros G., et al.
Publicado: (2017) -
Translation of Cardiac Myosin Activation With 2-Deoxy-ATP to Treat Heart Failure Via an Experimental Ribonucleotide Reductase-Based Gene Therapy
por: Thomson, Kassandra S., et al.
Publicado: (2016) -
Failure to Launch: Targeting Inflammation in Acute Coronary Syndromes
por: Rymer, Jennifer A., et al.
Publicado: (2017)